Hillsdale Investment Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-49,230
| Closed | -$4.21M | – | 632 |
|
|
2023
Q4 | $4.21M | Sell |
49,230
-110
| -0.2% | -$9.41K | 0.34% | 96 |
|
|
2023
Q3 | $4.42M | Buy |
49,340
+20
| +0% | +$1.79K | 0.4% | 72 |
|
|
2023
Q2 | $4.2M | Sell |
49,320
-18,280
| -27% | -$1.56M | 0.39% | 96 |
|
|
2023
Q1 | $5.59M | Buy |
67,600
+8,700
| +15% | +$720K | 0.48% | 62 |
|
|
2022
Q4 | $4.63M | Buy |
+58,900
| New | +$4.63M | 0.39% | 89 |
|
|
2020
Q3 | – | Sell |
-6,900
| Closed | -$618K | – | 608 |
|
|
2020
Q2 | $618K | Sell |
6,900
-30,860
| -82% | -$2.76M | 0.06% | 285 |
|
|
2020
Q1 | $3.76M | Sell |
37,760
-800
| -2% | -$79.7K | 0.45% | 48 |
|
|
2019
Q4 | $4.43M | Buy |
38,560
+4,200
| +12% | +$483K | 0.39% | 80 |
|
|
2019
Q3 | $4.33M | Buy |
34,360
+27,460
| +398% | +$3.46M | 0.38% | 60 |
|
|
2019
Q2 | $830K | Buy |
6,900
+1,300
| +23% | +$156K | 0.08% | 214 |
|
|
2019
Q1 | $490K | Sell |
5,600
-19,100
| -77% | -$1.67M | 0.04% | 321 |
|
|
2018
Q4 | $2.47M | Buy |
24,700
+7,700
| +45% | +$770K | 0.29% | 52 |
|
|
2018
Q3 | $1.95M | Hold |
17,000
| – | – | 0.26% | 62 |
|
|
2018
Q2 | $1.53M | Sell |
17,000
-1,000
| -6% | -$89.7K | 0.19% | 95 |
|
|
2018
Q1 | $1.32M | Sell |
18,000
-5,000
| -22% | -$366K | 0.18% | 102 |
|
|
2017
Q4 | $1.34M | Buy |
+23,000
| New | +$1.34M | 0.22% | 91 |
|